F 0604
Ensure that each resident is free from the use of physical restraints, unless needed for medical treatment.
Level of Harm - Minimal harm
or potential for actual harm
Based on observation, medical record and staff interview the facility failed to ensure assessments were
completed to determine if a device being utilized limited a resident's freedom of activity or movement
indicating the use of a physical restraint. This affected one (Resident #89) of one residents reviewed for
possible restraint use. The facility identified no residents currently utilizing restraint devices. The facility
census was 39.
Residents Affected - Few
Findings include:
Review of Resident #89's medical record revealed an admission date of 02/20/25 with diagnoses that
included vascular dementia, hypertension, hyperlipidemia and benign prostate hypertrophy.
Review of the resident's progress notes dated 02/22/25 revealed the resident utilized a tilt-in-space
wheelchair.
Review of Resident #89's assessments revealed no evidence of any assessment completed to determine if
the tilt-in-space wheelchair was a restraining device or an enabling device for resident comfort.
Observation of Resident #89 on 03/03/25 at 9:30 A.M. revealed the resident was seated in a reclined
tilt-in-space wheelchair (wheelchair which the seating surface and seat back can be reclined) in his room.
Additional observation on 03/05/25 at 11:50 A.M. revealed the resident was seated in a reclined
tilt-in-space wheelchair in his room.
On 03/04/25 at 10:30 A.M. interview with the Director of Nursing verified the facility had not completed an
assessment to determine if the tilt-in-space wheelchair was a restraint and prevented the resident's
freedom of activity or movement or if the wheel chair was an enabling device.
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 4
Event ID:
366449
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
366449
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
03/06/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Park Village Hc NP LLC
1019 Oldtown Valley Road SE
New Philadelphia, OH 44663
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0684
Provide appropriate treatment and care according to orders, resident’s preferences and goals.
Level of Harm - Minimal harm
or potential for actual harm
Based on observation, interview, and medical record review the facility failed to ensure Resident #32's
physician orders related to wrapping his bilateral legs and feet were followed. This affected one (Resident
#32) of one residents reviewed for edema. The facility census was 39.
Residents Affected - Few
Findings include:
Review of the medical record for Resident #32 revealed an admission date of 11/09/24. Diagnoses include
congestive heart failure (CHF), unspecified atrial fibrillation, and fluid overload.
Review of Resident #32's Minimum Data Set Assessment revealed the resident had intact cognition.
Review of Resident #32's care plan dated 02/19/25 revealed the resident has a fluid overload or potential
fluid volume overload related to CHF and edema. Interventions included ace wraps to bilateral lover
extremities to be put on in the morning and off at night.
Review of the nursing progress note dated 02/18/25 Registered Nurse #150 documented the wound
Certified Nurse Practitioner noted two plus edema to (the resident's) bilateral lower extremities. A new order
for ace wraps to the bilateral lower extremities to be put on in the A.M. and off at night.
Review of Resident #32's current physician orders revealed an order dated 02/18/25 to apply ace wraps to
bilateral lower extremities on in the A.M., take off in the P.M., and wrap from toes to knees. The order had
instructions to complete this every day shift.
Observation on 03/03/25 at 10:51 A.M. revealed Resident #32 was seated in his wheelchair. His feet were
resting on the floor and his legs and feet were noted to be moderately swollen. Observation on 03/04/25 at
2:11 P.M. revealed Resident #32 was seated in his wheelchair with his feet resting on the floor. His legs and
feet were noted to be moderately swollen.
Interview on 03/04/25 at 2:11 P.M. with Family Member #151 reported the facility frequently forgot to wrap
the resident's legs and feet. Family Member #151 reported that at the resident's most recent care
conference, the facility stated if he is not in bed, his legs and feet should be wrapped. She stated that lately
the facility had not been following this order.
Review of Resident #32's March 2025 Treat Administration Record revealed Registered Nurse (RN) #138
signed off that Resident #32's ace wraps were in place on 03/03/25 and 03/04/25.
Interview on 03/04/25 at 2:13 P.M. RN #138 verified she signed off that Resident #138 ace wraps were
applied to his bilateral lower extremities but confirmed they were not in place on 03/03/25 or 03/04/25. She
stated she would have one of the Certified Nursing Assistants apply them.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
366449
If continuation sheet
Page 2 of 4
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
366449
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
03/06/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Park Village Hc NP LLC
1019 Oldtown Valley Road SE
New Philadelphia, OH 44663
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0757
Ensure each resident’s drug regimen must be free from unnecessary drugs.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview, medical record review and policy review the facility failed to ensure Resident #3
received adequate monitoring for side effects related to the use of anticoagulant medication. This affected
one (Resident #3) of five residents reviewed for medication monitoring. The facility census was 39.
Residents Affected - Few
Findings include:
Review of the medical record for Resident #3 revealed an admission date of 10/06/2024. Diagnoses
included combined systolic and diastolic heart failure, paroxysmal atrial fibrillation, hypertensive heart and
chronic kidney disease with heart failure, and intracardiac thrombosis.
Review of Resident #3's physician orders revealed orders for apixaban (anticoagulant or blood thinning
medication) 5 milligrams (mg) by mouth two times a day for atrial fibrillation, Aspirin (blood thinning
medication) 81 mg by mouth one time a day related to atrial fibrillation, and clopidogrel disulfate
(antiplatelet) 75 mg by mouth one time a day for atrial fibrillation.
Review of Resident #3's significant change Minimum Data Set (MDS) assessment dated [DATE] revealed
Resident #3 had intact cognition and received anticoagulant medication (a medication that slows down or
prevents blood clotting).
Review of Resident #3's 01/20/25 plan of care revealed the resident is on anticoagulant therapy related to
atrial fibrillation. Interventions included to administer anticoagulant (medication) per physician order, daily
skin inspection and report abnormalities to the nurse, and observe/assess/document/report as needed
adverse reactions of anticoagulant therapy including blood tinged or red blood in urine, black tarry stools,
dark or bright red blood in stools, sudden severe headaches, nausea, vomiting, diarrhea, muscle joint pain,
lethargy, bruising , blurred vision, shortness of breath.
Observation on 03/03/25 at 9:11 A.M. revealed Resident #3 had notable bruising on her left hand spreading
across three fingers. A moderate size bruise to her right hand spreading across two fingers and another
bruise proximal to her thumb. An interview with Resident #3 at the time of the observation revealed the
resident reported that she was on blood thinning medication which caused her to bruise easily. She stated
that she probably hit her hands against something causing the bruising.
Review of Resident #3's nursing progress notes from 02/15/25 through 03/05/25 revealed no evidence of
bruising to Resident #3's bilateral hands or fingers was noted.
Interview on 03/05/25 at 10:01 A.M. with the Director of Nursing (DON) revealed that if a resident's care
plan stated to monitor a resident's skin daily and any issues, including bruising, should be documented in
the nursing progress notes.
Interview on 03/05/25 at 10:22 A.M. with the DON verified the facility did not complete daily anticoagulant
monitoring or assess and monitor the bruising to Resident #3's bilateral hands and fingers.
Review of the facility policy, Anticoagulant Policy and Procedure dated 10/2024 revealed residents on
anticoagulant therapy will be monitored for signs and symptoms of bleeding and or new or excessive
bruising. A physician or Certified Nurse Practitioner will be notified of any signs and symptoms
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
366449
If continuation sheet
Page 3 of 4
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
366449
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
03/06/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Park Village Hc NP LLC
1019 Oldtown Valley Road SE
New Philadelphia, OH 44663
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0757
of bleeding and or new excessive bruising.
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
366449
If continuation sheet
Page 4 of 4